Targeting PI3K/AKT/mTOR network for treatment of leukemia
Jessika Bertacchini(University of Modena and Reggio Emilia), Najmaldin Saki(Ahvaz Jundishapur University of Medical Sciences), Laura Mediani(University of Modena and Reggio Emilia), Ahmad Ahmadzadeh(Ahvaz Jundishapur University of Medical Sciences), Mohammad Shahjahani(Ahvaz Jundishapur University of Medical Sciences), Nazanin Heidari(Ahvaz Jundishapur University of Medical Sciences), Silvano Capitani(University of Ferrara)
Cited by 247
Related Papers
Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis?
|Experimental and Molecular Pathology|2019|168
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
|Endocrine Related Cancer|2008|144
Endothelial Cells: From Dysfunction Mechanism to Pharmacological Effect in Cardiovascular Disease
|Cardiovascular Toxicology|2018|126
STATs: An Old Story, Yet Mesmerizing
|DOAJ (DOAJ: Directory of Open Access Journals)|2016|124
Antioxidant and hepatoprotective effects of Capparis spinosa L. fractions and Quercetin on tert-butyl hydroperoxide- induced acute liver damage in mice
|Journal of Traditional and Complementary Medicine|2017|107